HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
94.51
-1.16 (-1.21%)
Dec 5, 2025, 4:00 PM EST - Market closed
HealthEquity Stock Forecast
Stock Price Forecast
According to 15 professional analysts, the 12-month price target for HealthEquity stock ranges from a low of $100 to a high of $134. The average analyst price target of $120.13 forecasts a 27.11% increase in the stock price over the next year.
Price Target: $120.13 (+27.11%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HealthEquity stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 7 | 8 | 9 | 9 | 8 | 8 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $125 | Buy | Maintains | $125 | +32.26% | Dec 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $126 → $129 | Buy | Maintains | $126 → $129 | +36.49% | Dec 4, 2025 |
| Citizens | Citizens | Buy Maintains $117 → $122 | Buy | Maintains | $117 → $122 | +29.09% | Dec 4, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $130 | Strong Buy | Reiterates | $130 | +37.55% | Dec 4, 2025 |
| BMO Capital | BMO Capital | Hold Initiates $100 | Hold | Initiates | $100 | +5.81% | Nov 13, 2025 |
Financial Forecast
Revenue This Year
1.32B
from 1.20B
Increased by 10.27%
Revenue Next Year
1.43B
from 1.32B
Increased by 8.24%
EPS This Year
3.91
from 1.09
Increased by 258.44%
EPS Next Year
4.54
from 3.91
Increased by 16.17%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4B | 1.5B | |
| Avg | 1.3B | 1.4B | |
| Low | 1.3B | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.5% | 16.1% | |
| Avg | 10.3% | 8.2% | |
| Low | 6.4% | 3.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.11 | 4.86 | |
| Avg | 3.91 | 4.54 | |
| Low | 3.67 | 4.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 276.7% | 24.4% | |
| Avg | 258.4% | 16.2% | |
| Low | 236.3% | 6.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.